Follicular Lymphoma Clinical Trial Space Intensifies with 45+ Companies in Active Development | DelveInsight The follicular lymphoma clinical trial analysis report delivers important insights into ...
NetraMark Holdings Inc. (the “Company” or “NetraMark”) (TSX: AIAI) (OTCQB: AINMF) (Frankfurt: PF0), a premier artificial intelligence (AI) company transforming clinical trials with AI-powered ...
Preclinical data showed enhanced anti-tumor activity and reduced cytokine release compared to conventional single-chain CAR T approaches -- Early clinical case from CELESTIAL-301 trial, the ...
Overall, TherVacB was found to be safe, well-tolerated, and highly immunogenic among the healthy study participants.
Versiti Clinical Trials Services (VCTS) has launched a partnership with 4D Path to bring cutting-edge treatment predictive biomarker technology to researchers developing lifesaving, personalized ...
MELBOURNE, Australia and NEW YORK, March 12, 2026 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (IXHL), a clinical-stage biopharmaceutical company developing innovative combination therapies, today ...
How are you and Formation Bio using AI to accelerate clinical development? We are building many AI tools and systems across the drug development lifecycle to help improve efficiency and outcomes, and ...
Demonstration batch production achieves all prespecified test specifications for dissolution, content uniformity, blend ...
At Formation Bio, we're leading the charge in reimagining drug development from the ground up using AI. We're an AI-native company, meaning we’re not just layering AI onto existing processes—we’re ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results